ClinConnect ClinConnect Logo
Search / Trial NCT01585857

ADIPOA - Clinical Study

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Apr 24, 2012

Trial Information

Current as of May 03, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • OA diagnosis should fulfil the criteria of the American College of Rheumatology (ACR) with moderate or severe medial and/ or external femorotibial knee osteoarthritis (OA) (stage 3 or 4) and indication total knee arthroplasty.
  • Exclusion Criteria:
  • Any disease or medication affecting the bone or cartilage metabolism, including corticoids.

About University Hospital, Montpellier

The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.

Locations

Montpellier, , France

Würzburg, , Germany

Patients applied

0 patients applied

Trial Officials

Christian Jorgensen, MD

Principal Investigator

University Hospital, Montpellier

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials